Zydus Lifesciences said its Desidustat tablets, licensed to a subsidiary of China Medical System Holdings (CMS), have been approved in China for treating renal anaemia by the National Medical Products ...
Tablets vs laptops: see how iPad Pro M4, Surface Pro 11, and others stack up for productivity, performance, and portability ...
Apple’s 2026 Ultra roadmap leaks! Discover the $2,000 iPhone Ultra, the first touchscreen MacBook Ultra, and AirPods Ultra ...
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily ...
China Medical System Holdings Limited ('CMS”, or the 'Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the 'Product”) has been approved for ...
A large body of evidence demonstrates the use of technology in schools is nuanced, with more downsides to technology use than most people expect.
Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and ...
TONMYA (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to ...
Parents were urged to read and speak to their children more ...
Uppsala, Sweden, March 12, 2026. Dicot Pharma AB announces that the company has successfully completed the development of LIB-01 as a tablet and initiated manufacturing of tablets ahead of the upcomin ...
Evidence from the past 20 years indicates that the use of computers in classrooms has led to declines in students' academic ...
TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results